New shortages have been reported for Norgeston (levonorgestrel) and Qlaira (estradiol valerate/dienogest), which are expected to be out of stock until the end of May and October 2021, respectively.
Several other contraceptive products are already listed on the MIMS drug shortages tracker:
- Akizza (ethinylestradiol/gestodene) - resupply date unknown
- Brevinor (ethinylestradiol/norethisterone) - expected back in stock this week
- Femodette (ethinylestradiol/gestodene) - due back in stock early May
- Norinyl-1 (mestranol/norethisterone) - resupply date unknown
- Yiznell (ethinylestradiol/drospirenone) - due back in stock this month.
Another ethinylestradiol/drospirenone product, Yasmin, is anticipated to be out of stock from early May until early July 2021.
In addition, the hormonal preparation Dianette (co-cyprindiol), used in the treatment of female acne and hirsutism, is currently out of stock until May.
The MIMS contraceptives table can help prescribers find suitable alternatives to products that are unavailable, although there are no exact equivalents available for Brevinor, Norinyl-1, Norgeston or Qlaira. The DHSC says unlicensed imports have been sourced for all of these products apart from Qlaira.